Analysis and Annealing Solution for Sudden Product Temperature Drop During Vacuum Pull-Down in Lyophilization

1. Observation

During lyophilization runs at the customer’s site, the following phenomenon was observed:

• After completion of the freezing step and at the onset of vacuum pull-down,

• The product temperature probe inside certain samples showed a sudden and sharp decrease,

• The indicated temperature temporarily dropped to approximately −60 °C to −70 °C,

• The temperature then gradually recovered once the chamber pressure stabilized.

This behavior occurred mainly during the initial vacuum application and was not observed simultaneously in all vials or probes.

2. Initial Assessment

Based on the review of the equipment performance and operating conditions, the following points were confirmed:

• The freeze dryer’s cooling capacity and shelf temperature performance are normal, with a minimum shelf temperature capability of −45 °C;

• The observed temperature drop does not indicate uncontrolled cooling or equipment malfunction;

• The phenomenon is characterized as a transient probe reading, rather than a uniform decrease in the true bulk product temperature.

3. Mechanism Analysis Under Vacuum Conditions

This phenomenon is most commonly associated with amorphous formulations, such as peptide and biological products, during the vacuum pull-down stage of lyophilization.

3.1 Characteristics of Amorphous Formulations

• Peptides and formulations containing stabilizing sugars (e.g., sucrose or trehalose) typically form an amorphous glassy matrix after freezing rather than a crystalline structure;

• Amorphous systems do not exhibit a distinct eutectic temperature and are instead governed by the glass transition temperature of the maximally freeze-concentrated solution (Tg′);

• Even below Tg′, such systems may retain a small amount of unfrozen or weakly bound water.

3.2 Evaporative Cooling During Vacuum Pull-Down

During the initial reduction of chamber pressure:

• Residual unfrozen moisture may undergo rapid evaporation (flash evaporation);

• This phase change absorbs latent heat from the immediate surroundings;

• Temperature probes in direct contact with the product, or with low thermal mass, can experience temporary evaporative cooling;

• As a result, the probe may display an artificially low temperature, which does not represent the actual bulk product temperature.

This effect is typically localized and short-lived.

3.3 Heat Transfer Changes Under Vacuum

• Upon evacuation, convective heat transfer inside the chamber is significantly reduced;

• If the temperature probe is not in perfect thermal contact with the frozen product, the loss of convection can amplify the apparent temperature drop;

• This behavior is more pronounced in high-water-content, low-solids, amorphous formulations.

4. Conclusion

Based on the above analysis, the sudden decrease in indicated product temperature during vacuum pull-down is attributed to:

• Evaporative cooling of residual unfrozen water in amorphous systems;

• Transient probe response under changing heat transfer conditions;

• Formulation and process-related factors, rather than freeze dryer hardware performance.

This behavior is a known and explainable phenomenon in lyophilization of peptide and biological products.

5. Mitigation Strategy: Introduction of an Annealing Step

To reduce residual unfrozen moisture and improve freezing uniformity in amorphous systems, the introduction of an annealing step during the freezing phase is recommended.

5.1 Purpose of Annealing

Annealing allows:

• Controlled growth and redistribution of ice crystals;

• Re-equilibration of water within the freeze-concentrated matrix;

• Reduction of free or weakly bound water susceptible to flash evaporation;

• Improved process stability during vacuum application and primary drying.

5.2 Recommended Annealing Cycle (Reference)

A typical annealing approach suitable for peptide and amorphous biological formulations is as follows:

1. Freeze the product to −45 °C and ensure complete solidification;

2. Increase shelf temperature to −20 °C to −25 °C and hold for 1–3 hours (above Tg′ but below the melting point);

3. Cool the shelves back to −45 °C;

4. Initiate vacuum pull-down and proceed to primary drying once thermal stability is achieved.

The exact annealing temperature and hold time should be optimized based on formulation-specific behavior.

6. Expected Improvements

With an appropriate annealing pre-treatment, the following improvements are typically observed:

• Smoother and more predictable product temperature profiles during vacuum pull-down;

• Significant reduction in transient low-temperature probe readings;

• Improved robustness and controllability of the primary drying phase;

• Enhanced cake structure and batch-to-batch consistency.

7. Summary

The observed sudden drop in product temperature during vacuum application is primarily related to the intrinsic physical behavior of amorphous formulations under vacuum, rather than equipment limitations. By implementing a controlled annealing step during freezing, this effect can be effectively mitigated, resulting in a more stable and robust lyophilization process.

Further verification and optimization will be conducted once the detailed freezing and annealing parameters used at the customer site are confirmed.